New Approach Blocks Staph Infections

Research supported by the National Institutes of Health has blocked staph infections in mice, and coming human trials will show whether it solves an worrisome trend: a staph bacterium that is increasingly resistant to antibiotics. The new approach, using a drug that had been tested in clinical trials as a cholesterol-lowering agent, was described in the February 14 online edition of Science.

"By following their scientific instinct about a basic biological process, the researchers made a surprising discovery with important clinical implications," said NIH Director Dr. Elias Zerhouni. "Although the results are still very preliminary, they offer a promising new lead for developing drugs to treat a very timely and medically important health concern."

This work was supported by three NIH units: the National Institute of General Medical Sciences, the National Institute of Allergy and Infectious Diseases, and the National Institute of Child Health and Human Development. NIH explains that a pigment turns Staphylococcus aureus golden and acts as an antioxidant to block the reactive oxygen molecules the immune system uses to kill bacteria. The researchers theorized that blocking pigment formation in staph may restore the immune system's ability to thwart infection. Reading a magazine on microbial research in 2005, Eric Oldfield, Ph.D., of the University of Illinois at Urbana-Champaign read how University of California, San Diego researchers knocked out a gene in staph's pigment-making pathway to create colorless, less pathogenic bacteria. "I looked at the metabolic pathway and noticed that it was similar to the one for the production of cholesterol in humans," said Oldfield, who is the senior author of the Science paper. Colleagues at Cedars-Sinai Medical Center in Los Angeles tested eight different drug compounds and found three blocked pigment production in laboratory tests. When the researchers treated mice infected with aureus with one of the compounds, the bacterial population was reduced by 98 percent.

Product Showcase

  • EMSL Analytical, Inc. - Air Sampling Supplies & Testing Labs

    EMSL Analytical, Inc. operates laboratories throughout the United States and Canada. EMSL is a nationally recognized and locally focused provider specializing in fast laboratory results for Asbestos, Mold, Silica, Lead & Metals, Bacteria, Legionella, USP , Combustion By-Products, VOC’s, Radon, PCB’s, Formaldehyde, METH/Fentanyl, Identification of Dust & Unknowns. Sampling Pumps, Cassettes, Media & Supplies available. Reach us at 1-800.220.3675 3

  • Full Line of Defense Against Combustible Dust Nilfisk

    Nilfisk provides a comprehensive range of industrial vacuums meticulously crafted to adhere to NFPA 652 housekeeping standards, essential for gathering combustible dust in Class I, Group D, and Class II, Groups E, F & G environments or non-classified settings. Our pneumatic vacuums are meticulously engineered to fulfill safety criteria for deployment in hazardous surroundings. Leveraging advanced filtration technology, Nilfisk ensures the secure capture of combustible materials scattered throughout your facility, ranging from fuels, solvents, and metal dust to flour, sugar, and pharmaceutical powders. 3

  • Safety Shower Test Cart

    The Safety Shower Test Cart speeds up and simplifies emergency shower tests, ensures you stay in compliance with OSHA regulations, and significantly reduces testing costs. With 7 unique features, the cart makes testing easy, effective, and efficient. You can test water clarity, flow, temperature, and spread—all at the same time! Most safety shower testing kits create a mess, take too much time to use, and don't fully help you stay in compliance with OSHA & ANSI standards. Transform the way you test emergency showers with Green Gobbler Safety. 3

Featured